首页 | 本学科首页   官方微博 | 高级检索  
检索        

老年弥漫大B细胞淋巴瘤的疗效分析
引用本文:孙凤飞,李婷婷,宋俊梅,李德智,别 俊,郭翠华,李光明.老年弥漫大B细胞淋巴瘤的疗效分析[J].现代肿瘤医学,2019,0(24):4451-4454.
作者姓名:孙凤飞  李婷婷  宋俊梅  李德智  别 俊  郭翠华  李光明
作者单位:川北医学院第二临床医院,四川 南充 637000
摘    要:目的:探讨影响老年弥漫大B细胞淋巴瘤治疗与预后的相关因素。方法:选取我院肿瘤科2008年7月至2014年7月收治的20例年龄大于65岁的弥漫大B细胞淋巴瘤病人,观察影响疗效及总生存率的各种变量,分析导致死亡的最主要因素。结果:16例病人接受治疗,4例病人未接受治疗。接受治疗的16例病人2年生存率为40%,中位生存时间为15个月。其中分期早、白蛋白高、IPI值2分以下、完成治疗的病人2年生存率高、预后好。利用COX比例风险回归模型分析感染、有无完成治疗是影响患者总生存期的因素。结论:感染是导致生存率下降的危险因素,也是导致死亡最主要的因素。

关 键 词:老年患者  弥漫大B细胞淋巴瘤  化疗  疗效

Clinical characteristics in diffuse large B cell lymphoma of elderly patient
Sun Fengfei,Li Tingting,Song Junmei,Li Dezhi,Bie Jun,Guo Cuihua,Li Guangming.Clinical characteristics in diffuse large B cell lymphoma of elderly patient[J].Journal of Modern Oncology,2019,0(24):4451-4454.
Authors:Sun Fengfei  Li Tingting  Song Junmei  Li Dezhi  Bie Jun  Guo Cuihua  Li Guangming
Institution:The Second Clinical College of North Sichuan Medical College,Sichuan Nanchong 637000,China.
Abstract:Objective:To investigate the therapy and prognostic factors of elderly patients with diffuse large B cell lymphoma (DLBCL).Methods:Samples were obtained from twenty patients (≥ 65 years of age) with diffuse large B cell lymphoma (DLBCL) from July 2008 to July 2014 in our hospital.We have observed the various variables which effects of response rate and overall survival time.Results:16 patients completed curative treatment and the 4 patients gave up curative treatment.The two-year survival rate was 40%,and the median survival time was 15 months for the 16 patients treated.The study showed the completion of treatment of patients who have early stage,high albumin level,IPI<2 had a better prognosis and high two-year survival rate.This paper analyzed the overall survival which effects of prognosis for patients by COX's proportional hazards regression model,which showed infection and treatment completed or not were influencing factors.Conclusion:Infection that results in survival rate dropped is particularly dangerous factor,also that is the most factor which lead to death.
Keywords:elderly patients  DLBCL  chemotherapy  curative effect
点击此处可从《现代肿瘤医学》浏览原始摘要信息
点击此处可从《现代肿瘤医学》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号